Quetiapine

Generic name: Pronounced as (kwe tye' a peen)
Brand names
  • Seroquel®
  • Seroquel® XR
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 06/15/2020

Important warning for older adults with dementia:

Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and that may cause changes in mood and personality) who take antipsychotics (medications for mental illness) such as quetiapine have an increased risk of death during treatment.

Quetiapine is not approved by the Food and Drug Administration (FDA) for the treatment of behavioral problems in older adults with dementia. Talk to the doctor who prescribed this medication if you, a family member, or someone you care for has dementia and is taking quetiapine. For more information visit the FDA website: http://www.fda.gov/Drugs

Important warning for people who have depression:

A small number of children, teenagers, and young adults (up to 24 years of age) who took medications for depression during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, experts are not sure about how great this risk is and how much it should be considered in deciding whether a child or teenager should take an antidepressant. Children younger than 10 years of age should not normally take quetiapine, but in some cases, a doctor may decide that quetiapine is the best medication to treat a child's condition.

You should know that your mental health may change in unexpected ways when you take quetiapine or other antidepressants even if you are an adult over age 24. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor when you are unable to seek treatment on your own.

Your healthcare provider will want to see you often while you are taking quetiapine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.

The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with quetiapine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the FDA website: http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm.

No matter what your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you.

Quetiapine tablets and extended-release (long-acting) tablets are used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Quetiapine tablets and extended-release tablets are also used alone or with other medications to treat episodes of mania (frenzied, abnormally excited or irritated mood) or depression in patients with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). In addition, quetiapine tablets and extended-release tablets are used with other medications to prevent episodes of mania or depression in patients with bipolar disorder. Quetiapine extended-release tablets are also used along with other medications to treat depression. Quetiapine tablets may be used as part of a treatment program to treat bipolar disorder and schizophrenia in children and teenagers. Quetiapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Quetiapine comes as a tablet and as an extended-release tablet to take by mouth. The tablets are usually taken one to three times a day with or without food. The extended-release tablets are usually taken once a day in the evening without food or with a light meal. Take quetiapine at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take quetiapine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow quetiapine extended-release tablets whole; do not split, chew, or crush them.

Your doctor will probably start you on a low dose of quetiapine and gradually increase your dose during the first week of your treatment. Ask your doctor or pharmacist if you have any questions about the amount of medication you should take each day at the beginning of your treatment.

If you do not take quetiapine for one week or longer, you should call your doctor before you start taking the medication again. Your doctor will probably tell you to start taking a low dose of the medication and gradually increase your dose as you did when you first started taking quetiapine.

Quetiapine may help control your symptoms but will not cure your condition. Continue to take quetiapine even if you feel well. Do not stop taking quetiapine without talking to your doctor. If you suddenly stop taking quetiapine, you may experience withdrawal symptoms such as nausea, vomiting, and difficulty falling asleep or staying asleep. Your doctor will probably want to decrease your dose gradually.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking quetiapine,

  • tell your doctor and pharmacist if you are allergic to quetiapine, any other medications. or any of the ingredients in quetiapine tablets or extended-release tablets. Ask your doctor or pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements and herbal products you are taking or plan to take. Be sure to mention any of the following: antidepressants; certain antifungals such as fluconazole (Diflucan), itraconazole (Onmel, Sporanox), ketoconazole (Nizoral), and voriconazole (Vfend); antihistamines; barbiturates such as phenobarbital; carbamazepine (Tegretol); chlorpromazine; divalproex (Depakote); certain medications for irregular heartbeat such as amiodarone (Nexterone), procainamide, quinidine, and sotalol (Betapace, Betapace AF, Sorine); dopamine agonists such as bromocriptine (Parlodel), cabergoline (Dostinex), levodopa (Dopar, Larodopa), pergolide (Permax), and ropinirole (Requip); erythromycin (E.E.S., E-Mycin, Erythrocin); gatifloxacin (Zymar, Zymaxid); levodopa (in Parcopa, in Sinemet, in Stalevo); levomethadyl acetate (Orlaam) (not available in the U.S.), medications for anxiety, high blood pressure, irritable bowel disease, mental illness, motion sickness, Parkinson's disease, ulcers, or urinary problems; medications for human immunodeficiency virus (HIV) such as indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Invirase); methadone (Dolophine, Methadose); moxifloxacin (Avelox, Moxeza, Vigamox); pentamidine (Nebupent, Pentam); phenytoin (Dilantin); rifampin (Rifadin, Rimactane); sedatives; oral steroids such as dexamethasone, methylprednisolone (Medrol), and prednisone (Rayos); sleeping pills; thioridazine (Mellaril); tranquilizers; and ziprasidone (Geodon). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you or anyone in your family has or has ever had diabetes or a prolonged QT interval (a rare heart problem that may cause irregular heartbeat, fainting, or sudden death). Also tell your doctor if you have ever used street drugs or overused prescription medications. Tell your doctor if you have or have ever had a low level of potassium or magnesium in your blood, a low number of white blood cells, are unable to completely empty your bladder, any condition that makes it difficult for you to swallow, trouble keeping your balance, seizures, cataracts, high cholesterol, high prolactin levels, an enlarged prostate, high or low blood pressure, a heart attack, a stroke, breast cancer or thyroid, heart or liver disease. Tell your doctor if you have constipation, severe vomiting, diarrhea or signs of dehydration now, or if you develop these symptoms at any time during your treatment. Also, if you have ever had to stop taking a medication for mental illness because of severe side effects, be sure to tell your doctor.

  • tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, or if you plan to become pregnant or are breastfeeding. If you become pregnant while taking quetiapine, call your doctor. Quetiapine may cause problems in newborns following delivery if it is taken during the last months of pregnancy. You should not breastfeed while taking quetiapine.

  • you should know that this medication may decrease fertility in women. Talk to your doctor about the risks of taking quetiapine.

  • if you are having surgery, including dental surgery, tell your doctor or dentist that you are taking quetiapine.

  • you should know that quetiapine may make you drowsy. Do not drive a car or operate machinery and take precautions to avoid falls until you know how this medication affects you.

  • you should know that alcohol can add to the drowsiness caused by this medication. Do not drink alcohol while taking quetiapine.

  • you should know that you may experience hyperglycemia (increases in your blood sugar) while you are taking this medication, even if you do not already have diabetes. If you have schizophrenia, you are more likely to develop diabetes than people who do not have schizophrenia, and taking quetiapine or similar medications may increase this risk. Tell your doctor immediately if you have any of the following symptoms while you are taking quetiapine: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include: dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.

  • you should know that quetiapine may make it harder for your body to cool down when it gets very hot. While you are taking quetiapine, you should avoid excessive exercise, stay inside as much as possible and dress lightly in hot weather, stay out of the sun, and drink plenty of fluids.

  • you should know that quetiapine may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking quetiapine and when your dose is increased. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

  • you should know that quetiapine may cause an increase in blood pressure in children and teenagers taking quetiapine. When quetiapine is used in children or teenagers, your doctor will check your blood pressure before starting treatment and regularly while you are taking this medication.

  • you should know that when quetiapine is used to treat schizophrenia or bipolar disorder in children, it should be used as part of a total treatment program which may include counseling and special education. Make sure to follow all of your doctor's and/or therapist's instructions.

Talk to your doctor about eating grapefruit and drinking grapefruit juice while taking this medicine.

You should know that you may gain weight while you are taking this medication. Talk to your doctor about ways to control weight gain, such as eating a healthy, balanced diet and exercising. You and your doctor should check your weight regularly while you are taking quetiapine.

Be sure to drink plenty of water every day while you are taking this medication.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Quetiapine may cause side effects. Tell your doctor if any of these symptoms or those listed in the SPECIAL PRECAUTIONS section are severe or do not go away:

    • dizziness, feeling unsteady, or having trouble keeping your balance

    • pain in the joints, back, neck, or ears

    • weakness

    • dry mouth

    • vomiting

    • indigestion

    • constipation

    • gas

    • stomach pain or swelling

    • increased appetite

    • excessive weight gain

    • stuffy nose

    • headache

    • pain

    • irritability

    • difficulty thinking or concentrating

    • difficulty speaking or using language

    • loss of coordination

    • unusual dreams

    • numbness, burning, or tingling in the arms or legs

    • missed menstrual periods

    • breast enlargement in males

    • discharge from the breasts

    • decreased sexual desire or ability

  • Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS section, call your doctor immediately or get emergency medical treatment:

    • fainting

    • falling

    • seizures

    • changes in vision

    • uncontrollable movements of your arms, legs, tongue, face, or lips

    • painful erection of the penis that lasts for hours

    • fever

    • muscle stiffness, pain, or weakness

    • excess sweating

    • fast or irregular heartbeat

    • confusion

    • unusual bleeding or bruising

    • sore throat, fever, chills, difficult or painful urination, or other signs of infection

    • hives

    • rash

    • blisters

    • tightening of the neck muscles or the throat

    • tongue sticking out

    • difficulty breathing or swallowing

  • Quetiapine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • Quetiapine may cause cataracts. You will need to have eye exams to check for cataracts at the beginning of your treatment and every six months during your treatment. Talk to your doctor about the risks of taking quetiapine.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • drowsiness

  • dizziness

  • fainting

  • fast heartbeat

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to quetiapine.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Quetiapine.
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be decreased when used in combination with Quetiapine.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quetiapine.
Delavirdine Delavirdine The serum concentration of Quetiapine can be increased when it is combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Quetiapine can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Quetiapine can be decreased when combined with Atorvastatin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Quetiapine.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quetiapine.
Bisacodyl Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quetiapine.
Candesartan Candesartan Candesartan may increase the hypotensive activities of Quetiapine.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Quetiapine.
Clopidogrel Clopidogrel The metabolism of Quetiapine can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Quetiapine.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Quetiapine can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Fenofibrate Fenofibrate Fenofibrate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Guanfacine Guanfacine Guanfacine may increase the hypotensive activities of Quetiapine.
Magnesium Hydroxide Magnesium Hydroxide Quetiapine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Magnesium Oxide Magnesium Oxide The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Quetiapine.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Quetiapine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Quetiapine.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Quetiapine.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Quetiapine.
Penbutolol Penbutolol Acebutolol may increase the hypotensive activities of Quetiapine.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Quetiapine.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Quetiapine.
Potassium Potassium Potassium may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Psyllium Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Quetiapine.
Ranitidine Ranitidine The metabolism of Quetiapine can be decreased when combined with Ranitidine.
Reserpine Reserpine Reserpine may increase the hypotensive activities of Quetiapine.
Rizatriptan Rizatriptan Rizatriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Sumatriptan Sumatriptan Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Tacrolimus Tacrolimus The metabolism of Quetiapine can be decreased when combined with Tacrolimus.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Quetiapine.
Triamcinolone Triamcinolone The metabolism of Quetiapine can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Quetiapine.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quetiapine.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Quetiapine.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Quetiapine.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Quetiapine.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Quetiapine.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Quetiapine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Quetiapine.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Quetiapine.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Quetiapine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Quetiapine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine Amphetamine may decrease the sedative and stimulatory activities of Quetiapine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Quetiapine can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Quetiapine.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quetiapine.
Torsemide Torsemide Quetiapine may increase the hypotensive activities of Torasemide.
Olanzapine Olanzapine Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Alosetron Alosetron Alosetron may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Dofetilide.
Entacapone Entacapone The therapeutic efficacy of Entacapone can be decreased when used in combination with Quetiapine.
Eprosartan Eprosartan Quetiapine may increase the hypotensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Quetiapine can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oxcarbazepine Oxcarbazepine The metabolism of Quetiapine can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Telmisartan Telmisartan Telmisartan may increase the hypotensive activities of Quetiapine.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Anakinra Anakinra The metabolism of Quetiapine can be increased when combined with Anakinra.
Desloratadine Desloratadine Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Quetiapine.
Rivastigmine Rivastigmine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Rivastigmine.
Trimipramine Trimipramine Trimipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Etanercept Injection Etanercept Injection The metabolism of Quetiapine can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate The risk or severity of adverse effects can be increased when Quetiapine is combined with Glycopyrronium.
Modafinil Modafinil The metabolism of Quetiapine can be increased when combined with Modafinil.
Perindopril Perindopril Perindopril may increase the hypotensive activities of Quetiapine.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Quetiapine.
Dutasteride Dutasteride The metabolism of Quetiapine can be decreased when combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The therapeutic efficacy of Quetiapine can be decreased when used in combination with Epinephrine.
Eplerenone Eplerenone Eplerenone may increase the hypotensive activities of Quetiapine.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Quetiapine.
Olmesartan Olmesartan Quetiapine may increase the hypotensive activities of Olmesartan.
Zonisamide Zonisamide Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Adalimumab Injection Adalimumab Injection The metabolism of Quetiapine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Quetiapine.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Quetiapine is combined with Dexmethylphenidate.
Atazanavir Atazanavir The serum concentration of Quetiapine can be increased when it is combined with Atazanavir.
Almotriptan Almotriptan Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Eletriptan Eletriptan Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Quetiapine.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Quetiapine.
Rosuvastatin Rosuvastatin The metabolism of Quetiapine can be decreased when combined with Rosuvastatin.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Quetiapine.
Alfuzosin Alfuzosin Alfuzosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Aprepitant Aprepitant The metabolism of Quetiapine can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Memantine Memantine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Memantine.
Tegaserod Tegaserod The metabolism of Quetiapine can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Tadalafil may increase the hypotensive activities of Quetiapine.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Quetiapine.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Quetiapine.
Progesterone Progesterone The metabolism of Quetiapine can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quetiapine.
Infliximab Injection Infliximab Injection The metabolism of Quetiapine can be increased when combined with Infliximab.
Protriptyline Protriptyline Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Rifaximin Rifaximin The metabolism of Quetiapine can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Quetiapine is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Quetiapine can be decreased when combined with Norethisterone.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Trospium Trospium Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Bosentan may increase the hypotensive activities of Quetiapine.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Quetiapine can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Quetiapine can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Quetiapine is combined with Eszopiclone.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Quetiapine.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Quetiapine.
Valganciclovir Valganciclovir Quetiapine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The serum concentration of Quetiapine can be increased when it is combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the sedative and stimulatory activities of Quetiapine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Quetiapine can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Quetiapine.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be decreased when used in combination with Quetiapine.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Quetiapine.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Quetiapine is combined with Isocarboxazid.
Ramelteon Ramelteon Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Darifenacin Darifenacin The metabolism of Quetiapine can be decreased when combined with Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Quetiapine is combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Quetiapine can be increased when used in combination with Pregabalin.
Phenylephrine Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Quetiapine.
Tipranavir Tipranavir The serum concentration of Quetiapine can be increased when it is combined with Tipranavir.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Quetiapine.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Quetiapine.
Ranolazine Ranolazine The serum concentration of Quetiapine can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Quetiapine can be increased when combined with Abatacept.
Rasagiline Rasagiline Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Imatinib is combined with Quetiapine.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Quetiapine.
Varenicline Varenicline Quetiapine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Quetiapine can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Quetiapine.
Paliperidone Paliperidone Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.
Bortezomib Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Quetiapine.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Quetiapine.
Lubiprostone Lubiprostone Quetiapine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Quetiapine.
Posaconazole Posaconazole The serum concentration of Quetiapine can be increased when it is combined with Posaconazole.
Primaquine Primaquine The metabolism of Quetiapine can be decreased when combined with Primaquine.
Aliskiren Aliskiren Quetiapine may increase the hypotensive activities of Aliskiren.
Darunavir Darunavir The serum concentration of Darunavir can be increased when it is combined with Quetiapine.
Pemetrexed Injection Pemetrexed Injection Quetiapine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Quetiapine.
Lisdexamfetamine Lisdexamfetamine Lisdexamfetamine may decrease the sedative and stimulatory activities of Quetiapine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Quetiapine.
Sorafenib Sorafenib The metabolism of Quetiapine can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Quetiapine.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Quetiapine.
Pegaptanib Injection Pegaptanib Injection Quetiapine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Quetiapine.
Mexiletine Mexiletine The metabolism of Quetiapine can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Quetiapine can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Quetiapine.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Quetiapine.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nilotinib Nilotinib The serum concentration of Quetiapine can be increased when it is combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Toremifene is combined with Quetiapine.
Budesonide Budesonide The metabolism of Quetiapine can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Quetiapine can be decreased when combined with Chloramphenicol.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Betaine Betaine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Glycine betaine.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum Toxin Type B.
Doripenem Injection Doripenem Injection Quetiapine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Quetiapine.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Quetiapine is combined with Desvenlafaxine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nebivolol Nebivolol Quetiapine may increase the hypotensive activities of Nebivolol.
Tretinoin Tretinoin The metabolism of Quetiapine can be decreased when combined with Tretinoin.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Quetiapine.
Certolizumab Injection Certolizumab Injection The metabolism of Quetiapine can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The metabolism of Quetiapine can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Quetiapine can be decreased when combined with Praziquantel.
Mitotane Mitotane The metabolism of Quetiapine can be increased when combined with Mitotane.
Methylnaltrexone Injection Methylnaltrexone Injection Quetiapine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Quetiapine.
Silodosin Silodosin Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Silodosin.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Quetiapine.
Naltrexone Injection Naltrexone Injection The risk or severity of adverse effects can be increased when Naltrexone is combined with Quetiapine.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Quetiapine is combined with Milnacipran.
Plerixafor Injection Plerixafor Injection Quetiapine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Quetiapine.
Fesoterodine Fesoterodine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Quetiapine.
Betaxolol Betaxolol Betaxolol may increase the hypotensive activities of Quetiapine.
Iloperidone Iloperidone Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Prasugrel Prasugrel Quetiapine may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Quetiapine.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Quetiapine.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.
Pralatrexate Injection Pralatrexate Injection Quetiapine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Quetiapine.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Quetiapine.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Topotecan Topotecan Topotecan may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Quetiapine can be increased when combined with Golimumab.
Pazopanib Pazopanib The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Quetiapine.
Asenapine Asenapine Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Quetiapine.
Levonorgestrel Levonorgestrel The metabolism of Quetiapine can be decreased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Quetiapine is combined with Oxymorphone.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be decreased when used in combination with Quetiapine.
Tocilizumab Injection Tocilizumab Injection The metabolism of Quetiapine can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Quetiapine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Quetiapine.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Quetiapine.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Lurasidone Lurasidone Quetiapine may increase the hypotensive activities of Lurasidone.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Quetiapine.
Ipilimumab Injection Ipilimumab Injection Quetiapine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection The therapeutic efficacy of Quetiapine can be decreased when used in combination with Terbutaline.
Azilsartan Azilsartan The risk or severity of adverse effects can be increased when Quetiapine is combined with Azilsartan medoxomil.
Roflumilast Roflumilast Quetiapine may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be decreased when used in combination with Quetiapine.
Rilpivirine Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Quetiapine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Quetiapine can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Quetiapine can be decreased when combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Quetiapine.
Rivaroxaban Rivaroxaban Quetiapine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib Ruxolitinib Quetiapine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Quetiapine.
Clobazam Clobazam The metabolism of Quetiapine can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quetiapine.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Quetiapine.
Deferiprone Deferiprone Quetiapine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Quetiapine.
Crizotinib Crizotinib The metabolism of Quetiapine can be decreased when combined with Crizotinib.
Cabergoline Cabergoline Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Naloxone Injection Naloxone Injection The serum concentration of Quetiapine can be increased when it is combined with Naloxone.
Ambrisentan Ambrisentan Quetiapine may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ezogabine Ezogabine Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Iloprost Iloprost The risk or severity of adverse effects can be increased when Iloprost is combined with Quetiapine.
Enzalutamide Enzalutamide The metabolism of Quetiapine can be increased when combined with Enzalutamide.
Mirabegron Mirabegron The risk or severity of urinary retention can be increased when Quetiapine is combined with Mirabegron.
Linaclotide Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Quetiapine.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Quetiapine.
Teduglutide Injection Teduglutide Injection Quetiapine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Bedaquiline.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Quetiapine.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Quetiapine.
Pomalidomide Pomalidomide Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Quetiapine.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Quetiapine.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Quetiapine.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Quetiapine.
Ospemifene Ospemifene The metabolism of Quetiapine can be decreased when combined with Ospemifene.
Trametinib Trametinib Quetiapine may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Quetiapine is combined with Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Vortioxetine Vortioxetine The risk or severity of adverse effects can be increased when Quetiapine is combined with Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Quetiapine.
Avanafil Avanafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Avanafil is combined with Quetiapine.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Obinutuzumab.
Sofosbuvir Sofosbuvir Quetiapine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Quetiapine.
Apremilast Apremilast The metabolism of Quetiapine can be increased when combined with Apremilast.
Droxidopa Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Quetiapine.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Quetiapine can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be decreased when used in combination with Quetiapine.
Eslicarbazepine Eslicarbazepine Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oritavancin Injection Oritavancin Injection The metabolism of Quetiapine can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Quetiapine.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Suvorexant Suvorexant Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Quetiapine.
Edoxaban Edoxaban Quetiapine may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Quetiapine.
Methamphetamine Methamphetamine Metamfetamine may decrease the sedative and stimulatory activities of Quetiapine.
Tasimelteon Tasimelteon Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Riociguat Riociguat Quetiapine may increase the hypotensive activities of Riociguat.
Secukinumab Injection Secukinumab Injection The metabolism of Quetiapine can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Quetiapine may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be decreased when used in combination with Quetiapine.
Lenvatinib Lenvatinib The metabolism of Quetiapine can be decreased when combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Quetiapine can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Quetiapine can be decreased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Quetiapine.
Ivabradine Ivabradine Quetiapine may increase the QTc-prolonging activities of Ivabradine.
Amiloride Amiloride Amiloride may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Quetiapine may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Rolapitant Rolapitant The metabolism of Quetiapine can be decreased when combined with Rolapitant.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Quetiapine.
Brexpiprazole Brexpiprazole Brexpiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Quetiapine.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Quetiapine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of constipation can be increased when Quetiapine is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Quetiapine.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Quetiapine.
Ixazomib Ixazomib Quetiapine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Quetiapine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The metabolism of Quetiapine can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cobicistat Cobicistat The serum concentration of Quetiapine can be increased when it is combined with Cobicistat.
Midodrine Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Quetiapine.
Selexipag Selexipag Quetiapine may increase the hypotensive activities of Selexipag.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Quetiapine is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Quetiapine can be decreased when combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may increase the hypotensive activities of Quetiapine.
Rucaparib Rucaparib The metabolism of Quetiapine can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Quetiapine.
Ribociclib Ribociclib The serum concentration of Quetiapine can be increased when it is combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Plecanatide Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Quetiapine.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Deutetrabenazine.
Valbenazine Valbenazine Quetiapine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The metabolism of Quetiapine can be increased when combined with Deflazacort.
Safinamide Safinamide The metabolism of Quetiapine can be decreased when combined with Safinamide.
Naldemedine Naldemedine Quetiapine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The serum concentration of Quetiapine can be increased when it is combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Quetiapine can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Quetiapine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Quetiapine.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Quetiapine.
Acalabrutinib Acalabrutinib The metabolism of Quetiapine can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Quetiapine can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be decreased when used in combination with Quetiapine.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Quetiapine.
Buprenorphine Injection Buprenorphine Injection Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide The metabolism of Quetiapine can be increased when combined with Apalutamide.
Fostamatinib Fostamatinib The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Quetiapine.
Baricitinib Baricitinib Quetiapine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Quetiapine can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Quetiapine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Encorafenib.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Quetiapine.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Quetiapine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Quetiapine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quetiapine.
Dacomitinib Dacomitinib The metabolism of Quetiapine can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The serum concentration of Quetiapine can be increased when it is combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Quetiapine can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Quetiapine.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Quetiapine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Quetiapine can be decreased when combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Quetiapine can be increased when combined with Rifamycin.
Prucalopride Prucalopride Quetiapine may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Magnesium Citrate Magnesium Citrate The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Quetiapine.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Quetiapine can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of hypertension can be increased when Quetiapine is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Quetiapine is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Quetiapine.
Triclabendazole Triclabendazole The metabolism of Quetiapine can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Quetiapine.
Pitolisant Pitolisant The therapeutic efficacy of Pitolisant can be decreased when used in combination with Quetiapine.
Fedratinib Fedratinib The metabolism of Quetiapine can be decreased when combined with Fedratinib.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Quetiapine.
Phenytoin Injection Phenytoin Injection The metabolism of Quetiapine can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Quetiapine can be increased when combined with Fosphenytoin.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Quetiapine is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Lasmiditan.
Cenobamate Cenobamate The serum concentration of Quetiapine can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Quetiapine.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Quetiapine.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Quetiapine is combined with Selpercatinib.
Lemborexant Lemborexant Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Quetiapine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Quetiapine.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Quetiapine.
Pralsetinib Pralsetinib The metabolism of Quetiapine can be decreased when combined with Pralsetinib.
Opicapone Opicapone The therapeutic efficacy of Opicapone can be decreased when used in combination with Quetiapine.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Quetiapine can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Quetiapine is combined with Naxitamab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Quetiapine.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Quetiapine is combined with Viloxazine.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Theophylline Theophylline The metabolism of Quetiapine can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Quetiapine.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Hydroxyurea Hydroxyurea The metabolism of Quetiapine can be decreased when combined with Hydroxyurea.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Phenobarbital Phenobarbital The metabolism of Quetiapine can be increased when combined with Phenobarbital.
Metaxalone Metaxalone Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Quetiapine.
Primidone Primidone The metabolism of Quetiapine can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Quetiapine.
Diethylpropion Diethylpropion Diethylpropion may decrease the sedative and stimulatory activities of Quetiapine.
Chlorpromazine Chlorpromazine Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Quetiapine.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Quetiapine.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Quetiapine.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Quetiapine.
Lorazepam Lorazepam The serum concentration of Quetiapine can be increased when it is combined with Lorazepam.
Phenoxybenzamine Phenoxybenzamine Phenoxybenzamine may increase the hypotensive activities of Quetiapine.
Carmustine Carmustine Carmustine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Quetiapine.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Quetiapine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Quetiapine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Quetiapine.
Bromocriptine Bromocriptine Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Metaproterenol Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Quetiapine.
Tranylcypromine Tranylcypromine The metabolism of Quetiapine can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Quetiapine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Quetiapine.
Ergoloid Mesylates Ergoloid Mesylates Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Prochlorperazine Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Quetiapine.
Thioridazine Thioridazine The serum concentration of Quetiapine can be decreased when it is combined with Thioridazine.
Trifluoperazine Trifluoperazine Trifluoperazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dapsone Dapsone The metabolism of Quetiapine can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Quetiapine.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Quetiapine.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Quetiapine.
Oxybutynin Oxybutynin The metabolism of Quetiapine can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of adverse effects can be increased when Quetiapine is combined with Benzatropine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Quetiapine.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Quetiapine.
Orphenadrine Orphenadrine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Quetiapine.
Azathioprine Azathioprine Azathioprine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Quetiapine.
Phentermine Phentermine Phentermine may decrease the sedative and stimulatory activities of Quetiapine.
Methylphenidate Methylphenidate The risk or severity of adverse effects can be increased when Quetiapine is combined with Methylphenidate.
Amoxapine Amoxapine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Hydrocortisone Hydrocortisone The metabolism of Quetiapine can be decreased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Quetiapine can be decreased when combined with Doxorubicin.
Mechlorethamine Mechlorethamine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Mechlorethamine.
Pyridostigmine Pyridostigmine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Pyridostigmine.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Carbamazepine Carbamazepine The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Quetiapine.
Molindone Molindone The risk or severity of adverse effects can be increased when Quetiapine is combined with Molindone.
Methyldopa Methyldopa Methyldopa may increase the hypotensive activities of Quetiapine.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Quetiapine.
Prazosin Prazosin Prazosin may increase the hypotensive activities of Quetiapine.
Hydralazine Hydralazine Quetiapine may increase the hypotensive activities of Hydralazine.
Cimetidine Cimetidine The metabolism of Quetiapine can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Warfarin Warfarin Quetiapine may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Loperamide Loperamide The serum concentration of Quetiapine can be increased when it is combined with Loperamide.
Promethazine Promethazine Promethazine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Daunorubicin Daunorubicin The metabolism of Quetiapine can be increased when combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Digoxin Digoxin Digoxin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Quetiapine.
Chloroquine Chloroquine The metabolism of Quetiapine can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Quetiapine can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Quetiapine.
Triamterene Triamterene Triamterene may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Quetiapine.
Chlorothiazide Chlorothiazide Quetiapine may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone Chlorthalidone Quetiapine may increase the hypotensive activities of Chlorthalidone.
Metolazone Metolazone Metolazone may increase the hypotensive activities of Quetiapine.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The metabolism of Quetiapine can be decreased when combined with Clindamycin.
Secobarbital Secobarbital Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Desipramine Desipramine The metabolism of Quetiapine can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Imipramine Imipramine Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Probenecid Probenecid Probenecid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Quinidine Quinidine Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Quetiapine.
Isoniazid Isoniazid The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Quetiapine.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Rifampin Rifampin The metabolism of Quetiapine can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Quetiapine.
Tamoxifen Tamoxifen The metabolism of Quetiapine can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Quetiapine.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Methimazole Methimazole The serum concentration of Quetiapine can be increased when it is combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Quetiapine.
Glucagon Injection Glucagon Injection Quetiapine may increase the gastrointestinal motility reducing activities of Glucagon.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Quetiapine.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quetiapine.
Dextromethorphan Dextromethorphan Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quetiapine.
Niacin Niacin The metabolism of Quetiapine can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Quetiapine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Quetiapine.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Clemastine is combined with Quetiapine.
Chlorpheniramine Chlorpheniramine The metabolism of Quetiapine can be decreased when combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Quetiapine.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Quetiapine.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may increase the hypotensive activities of Quetiapine.
Dantrolene Dantrolene Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Quetiapine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Quetiapine.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Quetiapine.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Propranolol may increase the hypotensive activities of Quetiapine.
Minoxidil Minoxidil Quetiapine may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Pseudoephedrine may decrease the sedative and stimulatory activities of Quetiapine.
Nortriptyline Nortriptyline Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nadolol Nadolol Nadolol may increase the hypotensive activities of Quetiapine.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Quetiapine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Quetiapine.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quetiapine.
Trimethobenzamide Trimethobenzamide Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Flavoxate Flavoxate Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Quetiapine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Quetiapine.
Colchicine Colchicine Quetiapine may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Dacarbazine Dacarbazine Dacarbazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ketoconazole Ketoconazole The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Quetiapine is combined with Pyrantel.
Thiotepa Injection Thiotepa Injection The therapeutic efficacy of Thiotepa can be decreased when used in combination with Quetiapine.
Vincristine Injection Vincristine Injection The metabolism of Quetiapine can be decreased when combined with Vincristine.
Captopril Captopril Captopril may increase the hypotensive activities of Quetiapine.
Dipyridamole Dipyridamole The risk or severity of hypotension, dyspepsia, and headache can be increased when Dipyridamole is combined with Quetiapine.
Isoxsuprine Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Quetiapine.
Vinblastine Vinblastine The metabolism of Quetiapine can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may increase the hypotensive activities of Quetiapine.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Quetiapine.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Quetiapine is combined with Thiothixene.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Quetiapine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Quetiapine.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Quetiapine.
Dicyclomine Dicyclomine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Quetiapine.
Propantheline Propantheline Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Diltiazem Diltiazem Diltiazem may increase the hypotensive activities of Quetiapine.
Nifedipine Nifedipine The metabolism of Quetiapine can be decreased when combined with Nifedipine.
Timolol Timolol Timolol may increase the hypotensive activities of Quetiapine.
Verapamil Verapamil Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Atenolol Atenolol Atenolol may increase the hypotensive activities of Quetiapine.
Pindolol Pindolol Pindolol may increase the hypotensive activities of Quetiapine.
Cisplatin Injection Cisplatin Injection Cisplatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.
Etoposide Etoposide The metabolism of Quetiapine can be decreased when combined with Etoposide.
Glyburide Glyburide The therapeutic efficacy of Quetiapine can be decreased when used in combination with Glyburide.
Glipizide Glipizide The therapeutic efficacy of Quetiapine can be decreased when used in combination with Glipizide.
Indapamide Indapamide Indapamide may increase the hypotensive activities of Quetiapine.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Pentoxifylline Pentoxifylline The risk or severity of hypotension, dyspepsia, and headache can be increased when Pentoxifylline is combined with Quetiapine.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Quetiapine.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Labetalol Labetalol Labetalol may increase the hypotensive activities of Quetiapine.
Auranofin Auranofin Auranofin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quetiapine.
Gemfibrozil Gemfibrozil Quetiapine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz Quetiapine may increase the hypotensive activities of Guanabenz.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Pimozide Pimozide The metabolism of Quetiapine can be decreased when combined with Pimozide.
Enalapril Enalapril Enalapril may increase the hypotensive activities of Quetiapine.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Amiodarone Amiodarone The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Quetiapine.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Buspirone Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Quetiapine.
Lovastatin Lovastatin The metabolism of Quetiapine can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Quetiapine can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Fluoxetine Fluoxetine The serum concentration of Quetiapine can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine Nimodipine may increase the hypotensive activities of Quetiapine.
Clozapine Clozapine Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Quetiapine.
Idarubicin Idarubicin The metabolism of Quetiapine can be decreased when combined with Idarubicin.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Quetiapine.
Didanosine Didanosine Didanosine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Clarithromycin Clarithromycin The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.
Benazepril Benazepril Quetiapine may increase the hypotensive activities of Benazepril.
Etodolac Etodolac Etodolac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Felodipine Felodipine Felodipine may increase the hypotensive activities of Quetiapine.
Fosinopril Fosinopril Fosinopril may increase the hypotensive activities of Quetiapine.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Quinapril Quinapril Quetiapine may increase the hypotensive activities of Quinapril.
Ramipril Ramipril Ramipril may increase the hypotensive activities of Quetiapine.
Simvastatin Simvastatin The metabolism of Quetiapine can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Amlodipine may increase the hypotensive activities of Quetiapine.
Teniposide Injection Teniposide Injection The metabolism of Quetiapine can be decreased when combined with Teniposide.
Itraconazole Itraconazole The serum concentration of Quetiapine can be increased when it is combined with Itraconazole.
Lisinopril Lisinopril Lisinopril may increase the hypotensive activities of Quetiapine.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Quetiapine.
Bisoprolol Bisoprolol Bisoprolol may increase the hypotensive activities of Quetiapine.
Zolpidem Zolpidem Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin Doxazosin may increase the hypotensive activities of Quetiapine.
Terazosin Terazosin Terazosin may increase the hypotensive activities of Quetiapine.
Isradipine Isradipine Isradipine may increase the hypotensive activities of Quetiapine.
Omeprazole Omeprazole The metabolism of Quetiapine can be decreased when combined with Omeprazole.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Cisapride is combined with Quetiapine.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Quetiapine.
Fluvastatin Fluvastatin The metabolism of Quetiapine can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Quetiapine can be decreased when combined with Venlafaxine.
Nizatidine Nizatidine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Nizatidine.
Fluvoxamine Fluvoxamine The metabolism of Quetiapine can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The serum concentration of Quetiapine can be increased when it is combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Quetiapine.
Losartan Losartan Losartan may increase the hypotensive activities of Quetiapine.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Quetiapine.
Vinorelbine Injection Vinorelbine Injection The metabolism of Quetiapine can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Moexipril Moexipril Moexipril may increase the hypotensive activities of Quetiapine.
Lansoprazole Lansoprazole The metabolism of Quetiapine can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Quetiapine can be decreased when combined with Ifosfamide.
Nicardipine Nicardipine Nicardipine may increase the hypotensive activities of Quetiapine.
Bupropion Bupropion The metabolism of Quetiapine can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Quetiapine can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The serum concentration of Saquinavir can be increased when it is combined with Quetiapine.
Metformin Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Quetiapine.
Nisoldipine Nisoldipine Nisoldipine may increase the hypotensive activities of Quetiapine.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Quetiapine.
Amifostine Injection Amifostine Injection The risk or severity of adverse effects can be increased when Amifostine is combined with Quetiapine.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Quetiapine.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quetiapine.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Indinavir Indinavir The metabolism of Quetiapine can be decreased when combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Quetiapine can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Quetiapine.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Quetiapine can be decreased when combined with Clomipramine.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Mirtazapine Mirtazapine Quetiapine may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Quetiapine may increase the hypotensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Quetiapine is combined with Topiramate.
Valsartan Valsartan Quetiapine may increase the hypotensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quetiapine.
Pramipexole Pramipexole The therapeutic efficacy of Pramipexole can be decreased when used in combination with Quetiapine.
Donepezil Donepezil The therapeutic efficacy of Quetiapine can be decreased when used in combination with Donepezil.
Nelfinavir Nelfinavir The metabolism of Quetiapine can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Quetiapine.
Loratadine Loratadine Quetiapine may increase the anticholinergic activities of Loratadine.
Carvedilol Carvedilol Carvedilol may increase the hypotensive activities of Quetiapine.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Quetiapine.
Bicalutamide Bicalutamide The metabolism of Quetiapine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Sertraline is combined with Quetiapine.
Propafenone Propafenone The metabolism of Quetiapine can be decreased when combined with Propafenone.
Irbesartan Irbesartan Irbesartan may increase the hypotensive activities of Quetiapine.
Tamsulosin Tamsulosin Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Ropinirole Ropinirole The therapeutic efficacy of Ropinirole can be decreased when used in combination with Quetiapine.
Finasteride Finasteride The metabolism of Quetiapine can be decreased when combined with Finasteride.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Paroxetine Paroxetine The metabolism of Quetiapine can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The therapeutic efficacy of Tolcapone can be decreased when used in combination with Quetiapine.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Citalopram is combined with Quetiapine.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Efavirenz Efavirenz The serum concentration of Quetiapine can be increased when it is combined with Efavirenz.
Abacavir Abacavir Abacavir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Sildenafil Sildenafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Sildenafil is combined with Quetiapine.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Quetiapine.
Celecoxib Celecoxib The metabolism of Quetiapine can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Quetiapine can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Quetiapine.
Thalidomide Thalidomide Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Nateglinide Nateglinide The therapeutic efficacy of Quetiapine can be decreased when used in combination with Nateglinide.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Quetiapine.
Levetiracetam Levetiracetam Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Quetiapine can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists